Skip to main content
. 2019 Sep 24;14(6):373–381. doi: 10.1159/000502637

Fig. 2.

Fig. 2

Pattern of reimbursement of cancer medicines according to the 2016 ESMO survey in European Countries on cancer medicines availability and affordability [20]. The map reports an averaged estimation for the 4 medicines surveyed and must be intended as indicative.